CAFERGOT Safety Questions, CAFERGOT Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CAFERGOT. Our extensive database of CAFERGOT adverse events and CAFERGOT warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CAFERGOT
CAFERGOT Safety Reports
Total CAFERGOT reports: 9.CAFERGOT FDA safety alerts: 2002 .
Reported hospitalizations: 3.
Take CAFERGOT Side Effects Survey or Share Your CAFERGOT Story. CAFERGOT Usage.
Health Professional from UNITED STATES reported CAFERGOT problem on Jan 03, 2007. Female patient, 38 years of age, was diagnosed with migraine and was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: arterial stent insertion, peripheral artery dissection. CAFERGOT dosage: unknown. During the same period patient was treated with NEURONTIN, HEPARIN. Patient was hospitalized. Patient recovered.
CAFERGOT problem was reported by a Physician from BELGIUM on Jan 12, 2007. Female patient, 38 years of age, was diagnosed with migraine and was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: aortic valve disease, bicuspid aortic valve, blood cholesterol increased, cerebrovascular disorder, ergot poisoning, hemiparesis, protein total increased, pulse absent. CAFERGOT dosage: 6 MG - 8 MG, QW. Patient recovered.
Health Professional from UNITED KINGDOM reported CAFERGOT problem on Mar 27, 2007. Male patient, 69 years of age, was diagnosed with migraine and was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: amputation, hypertension. CAFERGOT dosage: unknown. During the same period patient was treated with PREDNISOLONE, FLUDROCORTISONE ACETATE, INSULIN LISPRO, INSULIN INSULATARD, ASPIRIN, DOXYCYCLINE, RIFAMPICIN. Patient was hospitalized. Patient recovered.
CAFERGOT problem was reported by a Consumer or non-health professional from AUSTRALIA on July 25, 2006. Male patient was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant, vascular bypass graft. CAFERGOT dosage: unknown. During the same period patient was treated with ACETAMINOPHEN W, SANDOMIGRAN, EZETROL, ENDEP, POLARAMINE. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported CAFERGOT problem on July 25, 2006. Male patient was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant, vascular bypass graft. CAFERGOT dosage: unknown. During the same period patient was treated with ACETAMINOPHEN W, SANDOMIGRAN, EZETROL, ENDEP, POLARAMINE. Patient recovered.
CAFERGOT problem was reported by a Consumer or non-health professional from AUSTRALIA on July 25, 2006. Male patient was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant, vascular bypass graft. CAFERGOT dosage: unknown. During the same period patient was treated with ACETAMINOPHEN W, SANDOMIGRAN, EZETROL, ENDEP, POLARAMINE. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported CAFERGOT problem on Nov 27, 2006. Male patient, 75 years of age, was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: mitral valve incompetence, tricuspid valve incompetence. CAFERGOT dosage: unknown. Patient recovered.
CAFERGOT problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 01, 2007. Female patient, 73 years of age, weighting 105.8 lb, was diagnosed with migraine, transient ischaemic attack, nausea, gastritis, asthma and was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, thrombolysis. CAFERGOT dosage: unknown. During the same period patient was treated with ASPIRIN, DOMPERIDONE, LANSOPRAZOLE, SERETIDE, SUMATRIPTAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported CAFERGOT problem on Sept 17, 2007. Female patient was diagnosed with headache and was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: anxiety, paraesthesia, somnolence. CAFERGOT dosage: unknown. Patient recovered.